share_log

PMGC Holdings | 8-K: Current report

PMGC Holdings | 8-K: Current report

PMGC Holdings | 8-K：重大事件
美股SEC公告 ·  2024/12/30 03:10

Moomoo AI 已提取核心訊息

Elevai Labs Inc. has successfully completed its reincorporation from Delaware to Nevada on December 20, 2024, and changed its name to PMGC Holdings Inc. The reincorporation was executed through a Plan of Merger dated November 22, 2024, with the company's common stock continuing to trade on The Nasdaq Capital Market under a new CUSIP number 28622K104.The corporate restructuring maintains the company's existing business operations, physical location, management, assets, liabilities, and net worth. Importantly, the reincorporation did not affect stockholders' percentage ownership interests or number of shares owned. The company's rights are now governed by Nevada corporation laws, including new Articles of Incorporation, Bylaws, and certificates of designation of preferred stock.
Elevai Labs Inc. has successfully completed its reincorporation from Delaware to Nevada on December 20, 2024, and changed its name to PMGC Holdings Inc. The reincorporation was executed through a Plan of Merger dated November 22, 2024, with the company's common stock continuing to trade on The Nasdaq Capital Market under a new CUSIP number 28622K104.The corporate restructuring maintains the company's existing business operations, physical location, management, assets, liabilities, and net worth. Importantly, the reincorporation did not affect stockholders' percentage ownership interests or number of shares owned. The company's rights are now governed by Nevada corporation laws, including new Articles of Incorporation, Bylaws, and certificates of designation of preferred stock.
Elevai Labs Inc. 於2024年12月20日成功完成了從特拉華州到內華達州的重新註冊，並將名稱更改爲PMGC Holdings Inc. 此次重新註冊通過2024年11月22日的合併計劃執行，公司普通股繼續在納斯達克資本市場交易，新的CUSIP號碼爲28622K104。公司重組保持了現有的業務運營、實體位置、管理、資產、負債和淨資產。重要的是，重新註冊沒有影響股東的百分比所有權或擁有的股份數量。公司的權利現在受內華達州公司法的管轄，包括新的公司章程、細則和優先股的指定證書。
Elevai Labs Inc. 於2024年12月20日成功完成了從特拉華州到內華達州的重新註冊，並將名稱更改爲PMGC Holdings Inc. 此次重新註冊通過2024年11月22日的合併計劃執行，公司普通股繼續在納斯達克資本市場交易，新的CUSIP號碼爲28622K104。公司重組保持了現有的業務運營、實體位置、管理、資產、負債和淨資產。重要的是，重新註冊沒有影響股東的百分比所有權或擁有的股份數量。公司的權利現在受內華達州公司法的管轄，包括新的公司章程、細則和優先股的指定證書。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Dogwood Therapeutics
    DWTX
    -- 13.350
    Transcode Therapeutics
    RNAZ
    -- 5.500
    Evaxion Biotech
    EVAX
    -- 3.640
    Hepion Pharmaceuticals
    HEPA
    -- 0.2000
    Nutriband
    NTRB
    -- 9.900
    解鎖完整榜單
    熱門中概股
    追蹤最熱門的中概股實時資訊。